Anti-PDGF antibody conjugated liposomes offer a targeted delivery mechanism for therapeutic agents directly to the affected retinal tissues in neovascular age-related macular degeneration (AMD), potentially enhancing treatment efficacy while minimizing systemic side effects. By harnessing the specificity of the anti-PDGF antibody, these liposomes may effectively inhibit the pathological vascular proliferation characteristic of neovascular AMD, thereby slowing disease progression. Furthermore, the use of liposomes as carriers facilitates the sustained release of drugs, which could improve patient compliance and overall treatment outcomes in managing this sight-threatening condition.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-757 | Recombinant Anti-PDGF Antibody | WB, FC, FuncS | IgG |
MHH-757 | Recombinant Human Anti-PDGF Antibody | WB, ELISA, FuncS | IgG |
ZG-491C | Mouse Anti-PDGF Recombinant Antibody (clone 1C3D3) | ELISA | Mouse IgG1, κ |
There are currently no Customer reviews or questions for VS-1024-FY278. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.